Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Clinician's Roundtable

A Deep Dive into the Pathophysiology of CAH and Its Impact on Treatment

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Related
Comments
  • Overview

    Congenital adrenal hyperplasia (CAH) can be caused by a 21-hydroxylase deficiency, which is a defect on chromosome 6. It’s not uncommon for parents to be unaware that they’re carriers of the mutation and pass it on to their kids. To learn about its impact on patients and the treatment landscape, join Dr. Charles Turck as he speaks with Dr. Craig Alter, Pediatric Endocrinologist and Director of the Neuroendocrine Center at the Children’s Hospital of Philadelphia.

Recommended
Details
Presenters
Related
Comments
  • Overview

    Congenital adrenal hyperplasia (CAH) can be caused by a 21-hydroxylase deficiency, which is a defect on chromosome 6. It’s not uncommon for parents to be unaware that they’re carriers of the mutation and pass it on to their kids. To learn about its impact on patients and the treatment landscape, join Dr. Charles Turck as he speaks with Dr. Craig Alter, Pediatric Endocrinologist and Director of the Neuroendocrine Center at the Children’s Hospital of Philadelphia.

Schedule14 Oct 2024